Kellanova has filed supplemental disclosures in response to litigation related to its proposed merger with Mars. The company faces complaints in New York and Illinois courts alleging inadequate disclosures in its proxy statement. While denying the claims' merit, Kellanova is voluntarily providing additional information to address the allegations.The supplemental disclosures include details on the merger background, financial projections, and analyses performed by advisors Lazard and Goldman Sachs. Key additions cover post-closing employment discussions, discounted cash flow assumptions, comparable company metrics, and precedent transaction data. Kellanova maintains the original disclosures were compliant but is supplementing to avoid potential delays.The company reaffirms its belief in the merger's benefits and urges shareholders to review all materials carefully before voting. Kellanova cautions that forward-looking statements involve risks and uncertainties that could cause actual results to differ from projections. The special shareholder meeting to vote on the merger remains scheduled for November 1, 2024.

Kellanova has filed supplemental disclosures in response to litigation related to its proposed merger with Mars. The company faces complaints in New York and Illinois courts alleging inadequate disclosures in its proxy statement. While denying the claims' merit, Kellanova is voluntarily providing additional information to address the allegations.The supplemental disclosures include details on the merger background, financial projections, and analyses performed by advisors Lazard and Goldman Sachs. Key additions cover post-closing employment discussions, discounted cash flow assumptions, comparable company metrics, and precedent transaction data. Kellanova maintains the original disclosures were compliant but is supplementing to avoid potential delays.The company reaffirms its belief in the merger's benefits and urges shareholders to review all materials carefully before voting. Kellanova cautions that forward-looking statements involve risks and uncertainties that could cause actual results to differ from projections. The special shareholder meeting to vote on the merger remains scheduled for November 1, 2024.